CELLECTRICON AB
Desconocido
BonePainIII: Identifying mechanisms and novel treatments of bone pain – closing the gap to the clinic.
CELLECTRICON AB
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2022-DN-01
Musculoskeletal pain from diseases such as arthritis and cancer in the bone affects the quality of life of millions and is a major societal...
2023-07-14 - 2027-12-31 | Financiado
2023-07-14 - 2027-12-31 | Financiado
BonePainII: A European Training Network to Combat Bone Pain
CELLECTRICON AB
participó en un
H2020:
H2020-MSCA-ITN-2018
In Europe 20 - 30% of adults are affected at any one time by musculoskeletal pain such as arthritic pain, lower back pain, pain from osteopo...
2018-08-20 - 2022-12-31 | Financiado
2018-08-20 - 2022-12-31 | Financiado
* No se disponen de datos de la empresa actual.